Project Grant R43EY038530
Award Date 8/1/26
Completion Date 7/31/27
Dollars Obligated $319K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Scarsdale, NY 10583, USA
Similar Awards
- The National Eye Institute awarded Carolina Instruments, Inc. $313,927 under the Vision Research program (CFDA 93.867) on July 15, 2026, to develop PUPIL-LIGHT, a wearable platform technology for acquiring high-speed, high-fidelity measurements of saccades, microsaccades, and pupil dynamics in real time. PUPIL-LIGHT uses photoplethysmography techniques with a camera-free design employing lightweight LEDs and sensors to measure pupil dynamics and fine eye movements at high sampling rates...
- The National Institutes of Health National Eye Institute awarded the University of Pittsburgh $403,633 on September 1, 2026, under the Vision Research program (CFDA 93.867) to develop a portable trans-palpebral tonometer (PT-2) for self-administered intraocular pressure measurement in glaucoma diagnosis and management. The research aims to advance a hand-held device based on solitary wave propagation technology that enables patients to self-administer IOP measurements at home without...
- The National Eye Institute awarded Biolight Engineering LLC $906,443 on July 1, 2026, under the Vision Research program (CFDA 93.867) to develop and validate PedCAM, an ultra-widefield, nonmydriatic pediatric fundus camera for retinopathy of prematurity (ROP) screening and pediatric retinal disease diagnosis. Biolight will finalize and fabricate five minimal viable product PedCAM systems incorporating pupil-matching control, adjustable illumination, autofocusing, and high dynamic range...
- The National Eye Institute, National Institutes of Health, awarded $1.234892 million to Intelon Optics, Inc. on September 15, 2025, under the Vision Research program (CFDA 93.867) to develop a next-generation Brillouin Optical Scanner System (BOSS) with improved speed, accuracy, and sensitivity for ocular biomechanics measurement. The project will translate research technology developed by Dr. Scarcelli at the University of Maryland into a commercially viable clinical device capable of detecting...
- The National Eye Institute awarded Neurofieldz Inc. $375,940 on September 15, 2025, under the Vision Research program (CFDA 93.867) to develop and validate a portable wireless diagnostic system for optic neuropathies and other diseases of the afferent visual system. Neurofieldz will conduct a Phase I Small Business Innovation Research feasibility study to advance NeuroVEP, a breakthrough sensor system that measures visual evoked potentials at the visual cortex using electric field...
- The National Eye Institute awarded Nanoscope Instruments, Inc., $1,019,678 on September 1, 2026, under the Vision Research program (CFDA 93.867) to develop and validate the Multi-Luminance Shape Discrimination Test, a device that measures functional vision in patients with moderate to severe vision loss. The recipient will evaluate the retest variability and performance of the Multi-Luminance Shape Discrimination Test in patients with geographic atrophy, wet age-related macular degeneration,...
- The National Eye Institute awarded Massachusetts Eye and Ear Infirmary $467,277 on July 1, 2026, under the Vision Research program (CFDA 93.867) to develop and validate a clinical neuropsychological assessment battery combined with mobile eye tracking to characterize the visuoperceptual profile of cerebral visual impairment. The testing battery comprises five standardized neuropsychological assessments focused on evaluating visual scanning, planning, processing speed, and visuomotor...
- The National Eye Institute awarded Aeon Imaging LLC $311,748 on August 15, 2026, under the Vision Research program (CFDA 93.867) to design, build, and demonstrate a more accurate visual acuity test device that corrects for optical artifacts common in aging eyes while remaining cost-competitive with electronic VA tests. Current visual acuity measurements in older patients are compromised by uncontrolled pupil size, retinal illuminance, wavefront aberrations, wide-field glare, and crowding...
- The National Eye Institute awarded Perzeption Inc. $305,406 on September 1, 2026, under the Vision Research program (CFDA 93.867) to develop and evaluate an efficient photostress recovery assessment method for age-related macular degeneration. The project addresses the need for sensitive functional biomarkers to detect early-stage AMD and measure disease progression or treatment response. Perzeption will develop a novel, personalized, adaptive testing method to assess photostress recovery in...
- The National Eye Institute awarded The Schepens Eye Research Institute $858,394 on August 1, 2026, under the Vision Research program (CFDA 93.867) to develop multimodal foundation models for eye disease screening and prognosis. The research develops a vision-language foundation model trained on pairs of retinal images and clinical notes to enable downstream supervised models for detection and progression prediction of age-related macular degeneration, diabetic retinopathy, and glaucoma. The...